3 July 2023 National Requirements for the Local Person for Pharmacovigilance (LPPV) in the EU, UK and Switzerland
22 June 2023 Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors
13 June 2023 Webinar – Requirements for a local contact person for pharmacovigilance: where do you need one?
20 April 2023 European Medicines Agency (EMA) strengthens PRIME (Priority Medicines) with new features
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 12 May 2026, 09:30 (CEST) to 12 May 2026, 13:30 (CEST) By EMA – Events
FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health By FDA – Press releases
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026 By EMA – News and press releases
Workshop on advancing proof-of-concept data in paediatric oncology drug development , Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 September 2026, 13:00 (CEST) to 21 September 2026, 16:00 (CEST) By EMA – Events
HMA/EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 November 2026 to 13 November 2026 By EMA – Events